The Lowy Medical Research Institute is uniquely structured compared to other nonprofit research organizations. LMRI is studying MacTel through partnerships with a cadre of biomedical experts from around the world. As such, the Institute represents a new strategy for disease-specific research.
At the Lowy Medical Research Institute, we work with experts in fields that we have identified as important for understanding Macular Telangiectasia type 2. These fields include advanced retinal imaging; genetics; the study of photoreceptors, Muller glia, retinal pigment epithelial cells, metabolism, and more. We have partnerships with individual researchers in these fields, and have forged a collaborative network between them. These partnerships form the core of our research program, and they complement our intramural research and clinical studies.
By working through partnerships, we are able to bring together some of the most talented vision scientists and clinical researchers from around the world to tackle a single disease: MacTel. The Lowy Medical Research Institute provides the framework to study the disease. As a group, we work together to answer specific questions. Each individual applies their own specialized knowledge and skill sets to the questions at hand.
The discoveries we make through researching MacTel may have broader applications to biomedical research. Some of what we learn about the eye through MacTel might lead to new therapies for other diseases. Because of the broadly applicable nature of our research, we also work in partnership with groups that are interested basic vision science. The results of our studies will deepen the biomedical community’s understanding of the eye and vision.